|
ASH1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.36239949614037E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.69340003025798E-10 |
| Normal-vs-Stage2 |
7.33699999977411E-07 |
| Normal-vs-Stage3 |
3.6706000000053E-05 |
| Normal-vs-Stage4 |
6.0257000000008E-05 |
| Stage1-vs-Stage2 |
8.798400E-01 |
| Stage1-vs-Stage3 |
7.984600E-01 |
| Stage1-vs-Stage4 |
8.003400E-01 |
| Stage2-vs-Stage3 |
7.346400E-01 |
| Stage2-vs-Stage4 |
8.480400E-01 |
| Stage3-vs-Stage4 |
6.684200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.82069972618638E-10 |
| Normal-vs-AfricanAmerican |
5.2042999909574E-09 |
| Normal-vs-Asian |
2.16379999995464E-06 |
| Caucasian-vs-AfricanAmerican |
6.370800E-01 |
| Caucasian-vs-Asian |
2.077800E-02 |
| AfricanAmerican-vs-Asian |
5.251500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40280009830462E-11 |
| Normal-vs-Female |
4.119200E-03 |
| Male-vs-Female |
2.555800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.86363999999939E-05 |
| Normal-vs-Extreme_Weight |
4.26260138297607E-11 |
| Normal-vs-Obese |
1.36390000005093E-06 |
| Normal-vs-Extreme_Obese |
6.4199000004983E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.513800E-01 |
| Normal_Weight-vs-Obese |
5.666000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.501400E-01 |
| Extreme_Weight-vs-Obese |
4.057800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.320000E-01 |
| Obese-vs-Extreme_Obese |
1.751390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.494050E-02 |
| Normal-vs-Age(41-60Yrs) |
7.23039999983577E-07 |
| Normal-vs-Age(61-80Yrs) |
1.19370069384672E-11 |
| Normal-vs-Age(81-100Yrs) |
5.42129999780983E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.647000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.074400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.054350E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.067600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.377900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.429000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.46569986650513E-10 |
| Normal-VS-Type2 PRCC |
2.21639995245937E-09 |
| Normal-VS-KIRP CIMP |
1.135160E-01 |
| Normal-VS-Unclassified PRCC |
2.680100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.932200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.448600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.273600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.649400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.007190E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.219400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08388861722142E-12 |
| Normal-vs-N1 |
5.042000E-02 |
| Normal-vs-N2 |
7.781400E-03 |
| N0-vs-N1 |
2.937800E-02 |
| N0-vs-N2 |
3.880600E-01 |
| N1-vs-N2 |
6.196800E-01 |
|
|
